About the AuthorMy name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
My ProfileI am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!
About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
Monthly Archives: July 2012
Yesterday marked the occasion of the commencement of the 19th International AIDS Conference being held here in Washington. Â It is the first time a conference has been held in the U.S. for many years. Â The theme for AIDS 2012 is … Continue reading
Heat. Humidity. Storm. Repeat. One forecast for tomorrow here in Washington has the temperature reaching 106 degrees. Perhaps the best thing one can do is stay indoors and have a cool drink handy. If one can be bothered to think … Continue reading
Yesterday the Washington Post carried a story about the latest polling from the Pew Research Center regarding the Supreme Court decision on the constitutionality of the Affordable Care Act. Needless to say, for those of us in healthcare and for … Continue reading